Showing results (21-30 of 34) with videos related to
Sort By:
Pageof 4
BMC Cancer|February 10, 2016
The MYCN-HMGA2-CDKN2A pathway in non-small cell lung carcinoma--differences in histological subtypesHanne A Eide, Ann Rita Halvorsen, Maria Moksnes Bjaanæs, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 31, 2011
EGFR gene alterations in a Norwegian cohort of lung cancer patients selected for surgeryÅslaug Helland, Hege Marian Skaug, Lilach Kleinberg, et al.Journal of Medicinal Chemistry|February 13, 2013
Selective mGAT2 (BGT-1) GABA uptake inhibitors: design, synthesis, and pharmacological characterizationStine B Vogensen, Lars Jørgensen, Karsten K Madsen, et al.Molecular Pharmacology|April 30, 2013
Structural determinants of agonist efficacy at the glutamate binding site of N-methyl-D-aspartate receptorsKasper B Hansen, Nami Tajima, Rune Risgaard, et al.Journal of the American Chemical Society|August 25, 2011
Enantioselective total syntheses of (-)-palau'amine, (-)-axinellamines, and (-)-massadinesIan B Seiple, Shun Su, Ian S Young, et al.Proceedings of the National Academy of Sciences of the United States of America|April 27, 2022
Convergent total synthesis of (+)-calcipotriol: A scalable, modular approach to vitamin D analogsJieyu Gu, Kevin X Rodriguez, Yuzuru Kanda, et al.FEBS Letters|May 18, 2011
Enzyme kinetic studies of histone demethylases KDM4C and KDM6A: towards understanding selectivity of inhibitors targeting oncogenic histone demethylasesJan B L Kristensen, Anders L Nielsen, Lars Jørgensen, et al.Journal of Medicinal Chemistry|June 27, 2008
N-Hydroxypyrazolyl glycine derivatives as selective N-methyl-D-aspartic acid receptor ligandsRasmus P Clausen, Caspar Christensen, Kasper B Hansen, et al.International Journal of Cancer|March 7, 2014
Unique microRNA-profiles in EGFR-mutated lung adenocarcinomasMaria Moksnes Bjaanaes, Ann Rita Halvorsen, Steinar Solberg, et al.Molecular Oncology|November 26, 2015
Genome-wide DNA methylation analyses in lung adenocarcinomas: Association with EGFR, KRAS and TP53 mutation status, gene expression and prognosisMaria Moksnes Bjaanæs, Thomas Fleischer, Ann Rita Halvorsen, et al.Pageof 4